- Home
- PCRX vs VEL Comparison
PCRX vs VEL Comparison
Compare PCRX & VEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCRX
- VEL
- Stock Information
- Founded
- PCRX 2006
- VEL 2004
- Country
- PCRX United States
- VEL United States
- Employees
- PCRX N/A
- VEL N/A
- Industry
- PCRX Biotechnology: Pharmaceutical Preparations
- VEL Finance: Consumer Services
- Sector
- PCRX Health Care
- VEL Finance
- Exchange
- PCRX Nasdaq
- VEL Nasdaq
- Market Cap
- PCRX 604.7M
- VEL 626.9M
- IPO Year
- PCRX 2011
- VEL 2020
- Fundamental
- Price
- PCRX $22.84
- VEL $18.79
- Analyst Decision
- PCRX Buy
- VEL Buy
- Analyst Count
- PCRX 10
- VEL 5
- Target Price
- PCRX $27.60
- VEL $20.80
- AVG Volume (30 Days)
- PCRX 787.3K
- VEL 72.1K
- Earning Date
- PCRX 02-27-2025
- VEL 03-06-2025
- Dividend Yield
- PCRX N/A
- VEL N/A
- EPS Growth
- PCRX N/A
- VEL 45.05
- EPS
- PCRX N/A
- VEL 1.84
- Revenue
- PCRX $694,957,000.00
- VEL $161,829,000.00
- Revenue This Year
- PCRX $4.83
- VEL N/A
- Revenue Next Year
- PCRX $2.16
- VEL $10.90
- P/E Ratio
- PCRX N/A
- VEL $10.25
- Revenue Growth
- PCRX 4.40
- VEL 35.27
- 52 Week Low
- PCRX $11.16
- VEL $14.51
- 52 Week High
- PCRX $34.01
- VEL $20.85
- Technical
- Relative Strength Index (RSI)
- PCRX 72.97
- VEL 35.99
- Support Level
- PCRX $18.18
- VEL $18.57
- Resistance Level
- PCRX $22.36
- VEL $19.06
- Average True Range (ATR)
- PCRX 1.17
- VEL 0.40
- MACD
- PCRX 0.33
- VEL -0.02
- Stochastic Oscillator
- PCRX 99.15
- VEL 14.62
About PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.
About VEL Velocity Financial Inc.
Velocity Financial Inc is a United States-based real estate finance company. The company originates and manages investor loans secured by residential rental and small commercial properties. The company earns revenue in the form of interest income. It operates in New York, California, Florida, New Jersey, and other states.